Picture of Scienture Holdings logo

SCNX — Scienture Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Scienture Secures $11.0 Million In Non-Dilutive Debt Financing To Accelerate Growth Of Approved Product Portfolio And Advancement Of Research And Development Pipeline

May 7 (Reuters) - Scienture Holdings Inc SCNX.O:

SCIENTURE SECURES $11.0 MILLION IN NON-DILUTIVE DEBT FINANCING TO ACCELERATE GROWTH OF APPROVED PRODUCT PORTFOLIO AND ADVANCEMENT OF RESEARCH AND DEVELOPMENT PIPELINE

SCIENTURE HOLDINGS - ENTERS DEFINITIVE AGREEMENT WITH SUMMIT BIOSCIENCES FOR EXCLUSIVE U.S. RIGHTS TO COMMERCIALIZE REZENOPY

Source text: ID:nGNX9LWdtj

Further company coverage: SCNX.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Scienture Holdings

See all news